These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18766323)

  • 21. Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis.
    Moreno PR; Astudillo L; Elmariah S; Purushothaman KR; Purushothaman M; Lento PA; Sharma SK; Fuster V; Adams DH
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):895-901. PubMed ID: 21481422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve.
    Kutryb-Zajac B; Jablonska P; Hebanowska A; Lango R; Rogowski J; Slominska EM; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1389-1399. PubMed ID: 32126886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mechanisms for osteogenic differentiation of human aortic valve interstitial cells.
    Wang Y; Xiao X; Zhou T; Han D; Dong N
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1742-1753.e7. PubMed ID: 31301902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease.
    Wu B; Elmariah S; Kaplan FS; Cheng G; Mohler ER
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):592-7. PubMed ID: 15618546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
    Thalji NM; Hagler MA; Zhang H; Casaclang-Verzosa G; Nair AA; Suri RM; Miller JD
    Circ Cardiovasc Genet; 2015 Jun; 8(3):516-28. PubMed ID: 25814644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic inflammation: A key role in degeneration of bicuspid aortic valve.
    Manno G; Bentivegna R; Morreale P; Nobile D; Santangelo A; Novo S; Novo G
    J Mol Cell Cardiol; 2019 May; 130():59-64. PubMed ID: 30885747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MAPK-Erk pathway in vivo attenuates aortic valve disease processes in Emilin1-deficient mouse model.
    Munjal C; Jegga AG; Opoka AM; Stoilov I; Norris RA; Thomas CJ; Smith JM; Mecham RP; Bressan GM; Hinton RB
    Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28270590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.
    Gee T; Farrar E; Wang Y; Wu B; Hsu K; Zhou B; Butcher J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):638-655. PubMed ID: 31893948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of TLR3 induces osteogenic responses in human aortic valve interstitial cells through the NF-κB and ERK1/2 pathways.
    Zhan Q; Song R; Zeng Q; Yao Q; Ao L; Xu D; Fullerton DA; Meng X
    Int J Biol Sci; 2015; 11(4):482-93. PubMed ID: 25798067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-catenin mediates mechanically regulated, transforming growth factor-β1-induced myofibroblast differentiation of aortic valve interstitial cells.
    Chen JH; Chen WL; Sider KL; Yip CY; Simmons CA
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):590-7. PubMed ID: 21127288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
    Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcific aortic valve disease should not be considered as a degenerative disease anymore.
    Li YB; Hu CL; Liu J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 68(6):1233-5. PubMed ID: 17011715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The degeneration of biological cardiovascular prostheses under pro-calcific metabolic conditions in a small animal model.
    Assmann A; Zwirnmann K; Heidelberg F; Schiffer F; Horstkötter K; Munakata H; Gremse F; Barth M; Lichtenberg A; Akhyari P
    Biomaterials; 2014 Aug; 35(26):7416-28. PubMed ID: 24917029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
    Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
    Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis.
    Hayami T; Funaki H; Yaoeda K; Mitui K; Yamagiwa H; Tokunaga K; Hatano H; Kondo J; Hiraki Y; Yamamoto T; Duong LT; Endo N
    J Rheumatol; 2003 Oct; 30(10):2207-17. PubMed ID: 14528519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p21WAF1/CIP1 and 14-3-3 sigma gene expression in degenerated aortic valves: a link between cell cycle checkpoints and calcification.
    Golubnitschaja O; Yeghiazaryan K; Skowasch D; Schild H; Bauriedel G
    Amino Acids; 2006 Oct; 31(3):309-16. PubMed ID: 16953367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased dietary intake of vitamin A promotes aortic valve calcification in vivo.
    Huk DJ; Hammond HL; Kegechika H; Lincoln J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):285-93. PubMed ID: 23202364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the molecular and cellular changes behind aortic valve stenosis.
    Falcão-Pires I; Gavina C; Leite-Moreira AF
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2485-96. PubMed ID: 22280423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different Notch signaling in cells from calcified bicuspid and tricuspid aortic valves.
    Kostina A; Shishkova A; Ignatieva E; Irtyuga O; Bogdanova M; Levchuk K; Golovkin A; Zhiduleva E; Uspenskiy V; Moiseeva O; Faggian G; Vaage J; Kostareva A; Rutkovskiy A; Malashicheva A
    J Mol Cell Cardiol; 2018 Jan; 114():211-219. PubMed ID: 29158034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways?
    Shworak NW
    Curr Opin Cardiol; 2004 Mar; 19(2):140-6. PubMed ID: 15075741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.